+1 877 705 191424 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 12Years +
All Genders
ID04924712

Controlled Multicenter Study of Peripheral Immune Cells and Microbiota in Idiopathic Nephrotic Syndrome Patients

Led by Nantes University Hospital · Updated on 2026-03-03

30

Participants Needed

2

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are studying idiopathic nephrotic syndrome INS, a kidney condition marked by protein loss in urine, low blood protein levels, and specific kidney tissue changes. The cause of INS is unknown, but immune system involvement is suspected, including links with allergies, diet, and gut bacteria imbalance. The study explores how immune cells and microbiota may relate to INS and its recurrence after kidney transplantation. This observational study collects blood, urine, and feces samples from patients with nephrotic syndrome to analyze their immune cell populations and microbiota composition using advanced sequencing methods. Participants include those with idiopathic nephrotic syndrome and others with non-idiopathic nephrotic syndromes for comparison. Samples are taken at the start and again after three months to track changes over time. Participants will provide blood, urine, and stool samples during two visits three months apart without any changes to their usual treatment. Researchers will examine the immune cells and microbiota in these samples to understand differences between idiopathic and non-idiopathic nephrotic syndrome patients. The primary outcomes involve sequencing and analyzing the peripheral blood immune cells and intestinal and urinary microbiota, helping to uncover potential links between immune regulation, gut bacteria, and INS progression.

CONDITIONS

Brief Title

INS, B Cells and Microbiota

Who Can Participate

Age: 12Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patient treated in participating centers
  • Currently experiencing a nephrotic attack defined by proteinuria over 3g in 24 hours or a proteinuria/creatinuria ratio over 3 or as defined by the clinician
  • Aged 12 years or older
Not Eligible

You will not qualify if you...

  • History of nephrotic syndrome flare-ups resistant to corticosteroid therapy
  • Currently treated with immunosuppressant medication
  • Currently treated with corticosteroids at doses higher than 10 mg per day
  • Weighing less than 50 kg
  • Pregnant women
  • Under guardianship or curatorship

Research Team

C

Christophe Masset

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here